Clinical Trial Update: Visual and Economic Profits of ReSTOR® Multifocal Intraocular Lenses (IOL) on Public Health Patients in Spain [NA]

View source ↗

Summary

Clinical trial update examining visual and economic outcomes of ReSTOR multifocal intraocular lenses for presbyopia in Spain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• ReSTOR Multifocal Intraocular Lenses (IOL)

Snippet

Sponsor: University of Barcelona | Conditions: Presbyopia | NA | Status: UNKNOWN